静脉血栓症的实验室诊断教案编写 .pptVIP

静脉血栓症的实验室诊断;静脉血栓栓塞症;;;止血机制;内源性凝血途径 外源性凝血途径 共同凝血途径; VTE的危险因素 ——遗传性; There are remarkable difference in inherited risk factors between Caucasian and Chinese VTE patients ;*;*; VTE的危险因素 —— 继发性;遗传性易栓症;VTE在中国并不少见;病例 女 27岁 本次因右腘静脉血栓形成复发就诊。患者一年前因双下肢浮 肿，外院经肾脏活检诊断为IgA肾病，半年前首次发生右腘静脉血栓形成，当时给予溶栓和介入治疗，并口服华法令抗凝治疗。本次症状再发于外院进行溶栓和LMWH治疗。 父母非近亲结婚。其姐二年前于破宫产后发生下肢静脉血栓。;; 中华医学会呼吸病学分会 肺栓塞与肺血管病学组会议 静脉血栓栓塞症诊断、治疗 和预防指南 (讨论稿) 2010年5月28日重庆 ;RECORD2 3 Chinese data: conclusions;静脉血栓症的实验室诊断;易栓症常用检测项目;*;遗传性易栓症， 在ACL-TOP上检测 AT Protein C （凝固法） Protein C （发色法） Protein S (凝固法） Protein S (免疫法检测抗原） APC- R V ;Antithrombin;Free Protein S Ag;抗凝药物治疗 ;HIT： CLINICAL PRESENTATION;? We have been conducting the nationwide HIT registry for the patients who are suspected of having HIT (clinically). ? Physicians send the blood samples (serum and plasma) and clinical information of their patients who are suspected of having HIT to our laboratory. ? The results of HIT testing will usually be returned to the physicians within 24 hours after the arrival of the blood samples. ? Since August 2008, 375 cases have been enrolled from 190 hospitals. ;三种新口服抗凝药的特性和研究状态;